Roivant Sciences Ltd. (ROIV) Shareholders’ equity 2020–2025
Roivant Sciences Ltd. (ROIV) shareholders’ equity at each fiscal year-end, per SEC filings.
$4.5BFY2025 · since FY2020: $1.8B → $4.5B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.5B | -3.4% |
| FY2024 | $4.7B | -21.5% |
| FY2023 | $6.0B | +415.5% |
| FY2022 | $1.2B | -30.1% |
| FY2021 | $1.7B | -7.8% |
| FY2020 | $1.8B | — |
Source: SEC XBRL filings · For reference only · Not investment advice